SIM
KYTH

Sentry Investment Management’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Sentry Investment Management’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-2,209
Closed -$85K – 543
2014
Q2 		$85K Sell
2,209
-2,236
-50% -$78.1K ﹤0.01% 529
2014
Q1 		$177K Buy
+4,445
New +$199K 0.01% 518

Other funds holding KYTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Sentry Investment Management's KYTH Position: Q3 2014 in Review

Sentry Investment Management sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q3 2014, closing a stake of 2,209 shares — an estimated $85K sold.

Sentry Investment Management first reported a position in KYTH in Q1 2014 and held it in 2 quarters. The position peaked at $177K in Q1 2014. 110 funds tracked by Wall St. Rank hold KYTH as of Q3 2014.

  • Sentry Investment Management reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q3 2014 after selling out during the quarter.
  • Sentry Investment Management sold 2,209 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q3 2014, an estimated $85K.
  • Sentry Investment Management first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q1 2014 and held it in 2 quarters.
  • Sentry Investment Management's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $177K in Q1 2014.
  • 110 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q3 2014.

Based on Sentry Investment Management's 13F filing for Q3 2014, filed 13 Nov 2014.